Cargando…
Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19
In the current global emergency due to SARS-CoV-2 outbreak, passive immunotherapy emerges as a promising treatment for COVID-19. Among animal-derived products, equine formulations are still the cornerstone therapy for treating envenomations due to animal bites and stings. Therefore, drawing upon dec...
Autores principales: | León, Guillermo, Herrera, María, Vargas, Mariángela, Arguedas, Mauricio, Sánchez, Andrés, Segura, Álvaro, Gómez, Aarón, Solano, Gabriela, Corrales-Aguilar, Eugenia, Risner, Kenneth, Narayanan, Aarthi, Bailey, Charles, Villalta, Mauren, Hernández, Andrés, Sánchez, Adriana, Cordero, Daniel, Solano, Daniela, Durán, Gina, Segura, Eduardo, Cerdas, Maykel, Umaña, Deibid, Moscoso, Edwin, Estrada, Ricardo, Gutiérrez, Jairo, Méndez, Marcos, Castillo, Ana Cecilia, Sánchez, Laura, Sánchez, Ronald, Gutiérrez, José María, Díaz, Cecilia, Alape, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110969/ https://www.ncbi.nlm.nih.gov/pubmed/33972631 http://dx.doi.org/10.1038/s41598-021-89242-z |
Ejemplares similares
-
Clinical effects of immunization, bleeding, and albumin-based fluid therapy in horses used as immunoglobulin source to produce a polyspecific antivenom (Echitab-plus-ICP) towards venoms of African snakes
por: Huertas, Rose Mary, et al.
Publicado: (2023) -
Comparison of adjuvant emulsions for their safety and ability to enhance the antibody response in horses immunized with African snake venoms
por: Arguedas, Mauricio, et al.
Publicado: (2022) -
Intrageneric cross-reactivity of monospecific rabbit antisera against venoms of the medically most important Bitis spp. and Echis spp. African snakes
por: Gómez, Aarón, et al.
Publicado: (2022) -
In vitro Characterization of Anti-SARS-CoV-2 Intravenous Immunoglobulins (IVIg) Produced From Plasma of Donors Immunized With the BNT162b2 Vaccine and Its Comparison With a Similar Formulation Produced From Plasma of COVID-19 Convalescent Donors
por: Rojas-Jiménez, Gabriel, et al.
Publicado: (2022) -
In Vitro Tests for Assessing the Neutralizing Ability of Snake Antivenoms: Toward the 3Rs Principles
por: Gutiérrez, José María, et al.
Publicado: (2021)